Señales en vivo de IMMNOV.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 may 2024 @ 04:38):

Stats
Volumen de hoy	42 226.00
Volumen promedio	756 935
Capitalización de mercado	80.43M
EPS	SEK0 ( 2024-02-21 )
Próxima fecha de ganancias	( SEK0 ) 2024-06-04
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.340
ATR14	SEK0.0280 (1.58%)

Volumen Correlación

Largo: 0.09 (neutral)

Corto: 0.74 (moderate)

Signal:(52.031) Neutral

Immunovia AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immunovia AB (publ) Correlación - Moneda/Commodity

-0.55
( weak negative )

-0.57
( weak negative )

0.00
( neutral )

-0.63
( weak negative )

0.00
( neutral )

-0.69
( moderate negative )

Immunovia AB (publ) Finanzas

Annual	2023
Ingresos:	SEK1.58M
Beneficio Bruto:	SEK-5.11M (-324.25 %)
EPS:	SEK-7.38

FY	2023
Ingresos:	SEK1.58M
Beneficio Bruto:	SEK-5.11M (-324.25 %)
EPS:	SEK-7.38

FY	2022
Ingresos:	SEK1.15M
Beneficio Bruto:	SEK-3.07M (-267.77 %)
EPS:	SEK-5.95

FY	2021
Ingresos:	SEK844 000
Beneficio Bruto:	SEK15.81M (1 873.58 %)
EPS:	SEK-6.89

Financial Reports:

No articles found.

Immunovia AB (publ)

Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.